JAZZ vs REGN: Which Stock is Better?

Side-by-side comparison of Jazz Pharmaceuticals Plc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

JAZZ

Jazz Pharmaceuticals Plc

$203.42

REGN

Regeneron Pharmaceuticals Inc

$750.57

Key Metrics Comparison

MetricJAZZREGNWinner
Market Cap$12.52B$79.35BREGN
P/E RatioN/A18.08REGN
EPS (TTM)$N/A$41.51REGN
Revenue Growth0.1%0.0%JAZZ
Gross Margin91.7%44.6%JAZZ

Analyze JAZZ

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is JAZZ or REGN a better investment?

Comparing JAZZ and REGN: Jazz Pharmaceuticals Plc has a market cap of $12.52B while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between JAZZ and REGN?

JAZZ (Jazz Pharmaceuticals Plc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: JAZZ or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: JAZZ or REGN?

JAZZ has higher revenue growth at 0.1% vs 0.0% for REGN.

Which company is more profitable: JAZZ or REGN?

Jazz Pharmaceuticals Plc (JAZZ) has higher gross margins at 91.7% compared to 44.6% for REGN.

Which is the larger company: JAZZ or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $12.52B for JAZZ.

Should I buy JAZZ or REGN in 2026?

Both JAZZ and REGN have investment merit. JAZZ trades at $203.42 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between JAZZ and REGN stock?

Key differences: Market Cap ($12.52B vs $79.35B), P/E Ratio (N/A vs 18.1x), Revenue Growth (0.1% vs 0.0%), Gross Margin (91.7% vs 44.6%).

Popular Stock Comparisons